Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004997-23Phase 2Completed
Phase 2, randomised, double-blind trial in gastroparesis comparing M0003 with Placebo (2 arms). Primary endpoint: Exploratory symptom efficacy. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004997-23.